Owlet (OWLT) Net Cash Flow Growth (1y) (2021 - 2026)
Owlet (OWLT) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 76.43% |
| 10 | Owlet | 146.68 Mn | 105.67 Mn | 12.24 Mn | 99.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.95% |
| Dec 31, 2025 | 1,455.00% |
| Sep 30, 2025 | -70.35% |
| Jun 30, 2025 | 281.84% |
| Mar 31, 2025 | -318.53% |
| Dec 31, 2024 | -189.87% |
| Sep 30, 2024 | 168.04% |
| Jun 30, 2024 | -15,868.42% |
| Mar 31, 2024 | -86.40% |
| Dec 31, 2023 | 111.66% |
| Sep 30, 2023 | 31.96% |
| Jun 30, 2023 | 99.94% |
| Mar 31, 2023 | 151.43% |
| Dec 31, 2022 | 39.81% |
| Sep 30, 2022 | -113.71% |
| Jun 30, 2022 | -5,208.77% |
| Mar 31, 2022 | -526.89% |
| Dec 31, 2021 | -1,641.44% |
| Sep 30, 2021 | 5,810.49% |